Inflazome
Signals that cause immune cells to fight infections
Inflazome has raised €56M across 3 funding rounds from 4 investors, most recently a round in Jan 2019. Based in Dublin, Ireland; founded 2016; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€56M
€56,028,670
Funding rounds
3
Investors
4
distinct backers
Active since
2016-09
latest 2019-01
Funding by year
EUR raised per yearInflazome — funding by year — interactive chart.
Data table
| Inflazome — funding by year | |
|---|---|
| 2016 | €15M |
| 2018 | €41M |
Signals
High confidenceRaise-next likelihood5
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood11
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 10y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-01-01 | Other | €873k | Michael J. Fox Foundation | View deal → |
| 2018-11-19 | Series B | €40M | Forbion | View deal → |
| 2016-09-01 | Series A | €15M | Fountain Healthcare Partners,Novartis Venture Fund | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Wayflyer€2.1BIreland · E-commerce
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData